Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 15;8(8):3530-9.
eCollection 2016.

Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients

Affiliations

Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients

Francesca Collina et al. Am J Transl Res. .

Abstract

Developing of personalized therapies for Triple Negative Breast Cancer (TNBC) requires a more detailed knowledge of its biology and a correct stratification of molecular subtypes. Androgen Receptor (AR) is expressed in a large part of TNBCs but its prognostic role in this Breast Cancer (BC) subtype is highly debated. In this study, we analyzed AR expression in a series of 238 TNBCs and correlated its expression with clinical-pathological features, survival, and metabolic profile. We showed a consistent association between AR expression and a better prognosis of TNBC patients, while its downregulation appeared strongly associated with diabetic disease. Since a recent prospective study reported a lower BC risk in diabetic women treated with drugs able to reduce circulating levels of glucose compared with non-diabetic woman, and in vitro studies showed that AR level are regulated directly by hyperglycemia, we speculate on the perspective of new integrated therapies for TNBC.

Keywords: Triple negative breast cancers; androgen receptor; diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
AR immunostaining in TNBC: A. Low expression of AR (10X); B. Detail of low expression of AR (20X); C. CK8/18 negative staining with normal tissue as positive internal control (10X); D. Detail of CK8/18 negative staining (20X).
Figure 2
Figure 2
LAR TNBC immunephenotype: A. High expression of AR (10X); B. Detail of high expression of AR (20X); C. CK8/18 positive staining (10X); D. Detail of CK8/18 positive staining (20X).
Figure 3
Figure 3
AR+ TNBC patients Kaplan-Meier curves: A. Disease Free Survival (DFS) (p=0.998); B. Overall Survival (OS) (p=0.035).
Figure 4
Figure 4
LAR TNBC patients Kaplan-Meier curves: A. Disease Free Survival (DFS) (p=0.277); B. Overall Survival (OS) (p=0.054).

Similar articles

Cited by

References

    1. Elsamany S, Abdullah S. Triple-negative breast cancer: future prospects in diagnosis and management. Med Oncol. 2014;31:834. - PubMed
    1. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of _targeted therapies. J Clin Invest. 2011;121:2750–2767. - PMC - PubMed
    1. Kim Y, Jae E, Yoon M. Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis. J Breast Cancer. 2015;18:134–142. - PMC - PubMed
    1. Ricciardi GR, Adamo B, Ieni A, Licata L, Cardia R, Ferraro G, Franchina T, Tuccari G, Adamo V. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging _targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS One. 2015;10:e0128368. - PMC - PubMed
    1. Choi JE, Kang SH, Lee SJ, Bae YK. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer. Ann Surg Oncol. 2015;22:82–89. - PubMed

LinkOut - more resources

  NODES
Association 2
INTERN 1
twitter 2